Skip to main content
. 2022 Mar 10;11(6):1528. doi: 10.3390/jcm11061528
AOR adjusted odds ratio
BIFAP base de datos para la investigación farmacoepidemiológica en atención primaria
BMI body mass index
CI confidence interval
COX cyclooxygenase
CRC colorectal cancer
CV cardiovascular
CVD cardiovascular disease
ES effect size
GI gastrointestinal
H2 type-2 histamine receptor
HMG-CoA  3-hydroxy-3-methylglutaryl-coenzyme A
ICPC international classification in primary care
ICD international classification of diseases
IQR interquartile range
LDL low-density lipoproteins
MICE multiple imputation by chained equations
NSAID nonsteroidal anti-inflammatory drugs
OR odds ratio
PCP primary care physician
PGE2 prostaglandin-E2
PPAR peroxisome proliferator-activated receptor
PRISMA preferred reporting items for systematic reviews and meta-analysis
PPI proton-pump inhibitors
SD standard deviation
SYSADOA symptomatic slow-acting drugs for osteoarthritis
USPSTF United States Preventive Services Task Force